Introducing the Sefia™ platform
Have you seen it? View the virtual launch event on demand.
Sefia™ cell therapy manufacturing platform: an end-to-end CAR T manufacturing solution.
When it comes to cell therapy manufacturing, you’re not just in production. You’re crafting hope for millions awaiting these breakthrough treatments. And excelling on this path to commercial realization craves the support of a platform made specifically for cell therapy manufacturing. A platform that not only provides flexibility and easy integration, but also boosts productivity and automates key steps of your workflow.
Breakaway from asking “what if”… it’s time to get after "what’s next."
Related content and resources
Automate your T cell isolation process
Manufacturing CAR T cell therapies? Learn how to use Sefia Select™ system with MagnetSelect.
Streamlined end-to-end manufacturing
See for yourself how Sefia™ platform handles the process from patient apheresis to final dose.
Manufacturing of autologous CAR T cell therapies
We put Sefia™ cell therapy manufacturing platform to the test. See how it performed in this poster.
Increased productivity at commercial scale
Designed with scalability in mind, Sefia™ platform optimizes footprint when scaling out. Watch now.
Automated cell washing and formulation
With Sefia Select™ system, built-in applications automate steps in CAR T cell therapy manufacturing.
COGs process economics for autologous cell therapy
It’s never too early to think about how you can reduce your cost of goods.
Get full control of your T cell isolation
Greater automation potential? This study explores MagnetSelect on Sefia Select™ system.
One of the main challenges of manufacturing autologous CAR T cell therapy is the cost. Open, manual operations are error- and contamination-prone. And if you’re thinking of scaling, the probability of these errors might just scale with you. But you can reduce the risk—while keeping flexibility—with closed and automated systems. Automation brings formerly discrete steps together, saving you time and money. Plus, by standardizing your process, you’re one step closer to meeting regulatory requirements—and to safely delivering your therapies to patients.